Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Mallinckrodt
Harvard Business School
AstraZeneca
Colorcon

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Dermatophagoides farinae

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Dermatophagoides farinae?

Dermatophagoides farinae is an investigational drug.

There have been 8 clinical trials for Dermatophagoides farinae. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2019.

The most common disease conditions in clinical trials are Rhinitis, Allergic, Rhinitis, and Inflammation. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), University of North Carolina, Chapel Hill, and Gachon University Gil Medical Center.

There are twenty-nine US patents protecting this investigational drug and two hundred and seventy international patents.

Recent Clinical Trials for Dermatophagoides farinae
TitleSponsorPhase
Anakinra as a Rescue Treatment for Allergic InflammationNational Heart, Lung, and Blood Institute (NHLBI)Phase 1/Phase 2
Anakinra as a Rescue Treatment for Allergic InflammationUniversity of North Carolina, Chapel HillPhase 1/Phase 2
Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway InflammationNational Heart, Lung, and Blood Institute (NHLBI)Phase 1/Phase 2

See all Dermatophagoides farinae clinical trials

Clinical Trial Summary for Dermatophagoides farinae

Top disease conditions for Dermatophagoides farinae
Top clinical trial sponsors for Dermatophagoides farinae

See all Dermatophagoides farinae clinical trials

US Patents for Dermatophagoides farinae

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dermatophagoides farinae   Start Trial Dermatophagoides farinae protein TAIHO PHARMACEUTICAL CO., LTD. (Chiyoda-ku, JP)   Start Trial
Dermatophagoides farinae   Start Trial Binding of allergens to a solid phase Abbott Laboratories (Abbott Park, IL)   Start Trial
Dermatophagoides farinae   Start Trial Method for controlling dust mites   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dermatophagoides farinae

Drugname Country Document Number Estimated Expiration Related US Patent
Dermatophagoides farinae China 107001434 2034-12-02   Start Trial
Dermatophagoides farinae European Patent Office 3228628 2034-12-02   Start Trial
Dermatophagoides farinae Japan WO2016088765 2034-12-02   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Medtronic
Mallinckrodt
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.